CP-II

Caplin Point has set up a dedicated pharmaceutical R&D facility with capabilities to develop safe and effective formulations. Sophisticated facilities and resources are available to develop dosage forms like Tablets, Capsules, Semi-solids (including suppositories), Liquid orals, Granules and Soft Geltin Capsules. The R & D facility is having separate teams for formulation development and analytical development. R & D scale stability studies, forced degradation studies, method development and validations are carried out in-house.

The following range of services are provided :

• Design and development of new dosage forms as per customer needs
• Process improvements and optimization
• Stability studies as per ICH guidelines
• Analytical development and Method validations as per ICH
• Technology transfer of new developed formulations
• Dissolution profiles as per CDER/EU guidelines

Location : Gummidipoondi, Chennai

CP-III / Argus

Caplin Point Laboratories Ltd Unit-III (Argus) is situated in the foothills town of Baddi in Himachal Pradesh with a panoramic view on Pinjore Nalagarh highway.

CP-III has the modern machinery to manufacture the topical formulations such as Ointments, Creams, Gels, Lotions and Capsules.

Location : Baddi, Himachal Pradesh

CP-IV

Caplin Point Laboratories Limited, Unit – IV (CP-IV) is a US FDA, EU-GMP, ANVISA and INVIMA approved manufacturing facility handling Pharmaceutical formulations in Specialized Injectable dosage forms and Ophthalmic drops. The facility is designed with a high level of sophistication and automated process control and is in compliance with norms stated by US FDA, UK MHRA and other regulatory bodies belonging to PIC/s.

The Site has a dedicated facility for formulation development, analytical development and stability department for product development in sterile dosage forms.

CP-IV is capable of handling general category and specialized category injectable dosages in Vial, Ampoules, Lyophilized Vials and Ophthalmic dosages.

The plant capacity is :

• Ampoules : 25 Million units per annum
• Vial : 25 Million units per annum
• Lyophilized Vials : 1.2 Million units per annum
• Ophthalmics : 12 Million units per annum

Location : Gummidipoondi, Chennai

CP- LL1

Caplin Point Laboratories LL-1 is a WHO-GMP approved facility, situated in Chennai.

The company has the facilities to manufacture:

• Tablets (β-lactam and non β-lactam)
• Capsules (β-lactam and non β-lactam)
• Liquid Orals (Syrup & Suspension) (Non β-lactam)
• Dry powder for Oral Suspension (β-lactam and non β-lactam)

Location : No. 3, Multi Industrial Nagar, Gerugambakkam,Chennai - 602 128.

CP- LL2

Caplin Point Laboratories LL-2 is a WHO-GMP approved facility, situated in Baddi, Himachal Pradesh. .

The company has the facilities to manufacture:

• Sterile Powder for Injections (β-lactam and non β-lactam)

Location : Plot No.4, Village Kunjhal, Near Jharmajri,, Baddi, Distt. Solan, Himachal Pradesh – 173205.